Login

Union Square Ventures is a venture capital firm|Brad Burnham,Partner,Union Square Ventures 00:10:00

Share On Facebook Share On Twitter

He started working in information technology with AT&T in 1979

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada
00:10:00
The Metals Company CFO Discusses Geopolitical Impact and Regulatory Timeline for Seafloor Mining
00:10:00
Power Minerals Explores High-Potential Lithium and Nickel-Cobalt Projects with Optimistic Drilling Results
00:10:00
Ireland's EU Journey and Identity Challenges|Mark Dooley,Professor,Boston College
00:10:00
Investing Basics: Why You Should Start Now with Laurel Hardy | Laurel Hardy, CEO, Bespoke Wealth Management.
00:10:00
Aspen Group: Navigating the Affordable Accommodation Sector Amidst Economic Shifts|CEO , Aspen Group Ltd
00:10:00
Focused solely on private equity|Saurabh Agarwal,Managing Director,Warburg Pincus LLC
00:10:00
Gordon Banham, CEO, highlights improved profits across all business segments in the company's interim results for the six months ended November 30, 2021.|Gordon Banham Group Chief Executive of Hargreaves Services PLC
00:10:00
Kickstart Your Retirement Savings: 5 Essential Steps with Andrea Belzer - Andrea Belzer | Personal Finance Educator | Aspirify, Inc.
00:10:00
helping find smart capital for every stage of company|Greg Castle,Managing Partner,Anorak Ventures
00:10:00
Cutting-Edge Cancer Therapies and Financial Strategies at the Biotech Showcase in San Francisco| Sadesh Seth , CEO, Actinium Pharmaceuticals Inc.
00:10:00
We are passionate customer-centric enablers. We empower our customers to deliver high performance through our unique end-to-end value proposition|Alain Conrard,CEO,Prodware SA

© 2017 - Neuhu+